These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28030848)

  • 1. A novel read-through transcript JMJD7-PLA2G4B regulates head and neck squamous cell carcinoma cell proliferation and survival.
    Cheng Y; Wang Y; Li J; Chang I; Wang CY
    Oncotarget; 2017 Jan; 8(2):1972-1982. PubMed ID: 28030848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
    Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
    Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of splicing proteins in head and neck squamous cell carcinoma.
    Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Chavan S; Nirujogi RS; Patil AH; Solanki H; Renuse S; Sahasrabuddhe NA; Mathur PP; Prasad TS; Kumar P; Califano JA; Sidransky D; Pandey A; Gowda H; Chatterjee A
    Cancer Biol Ther; 2016; 17(2):219-29. PubMed ID: 26853621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.
    Sikka A; Kaur M; Agarwal C; Deep G; Agarwal R
    Cell Cycle; 2012 Apr; 11(7):1374-82. PubMed ID: 22421144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
    Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
    J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
    Guha G; Lu W; Li S; Liang X; Kulesz-Martin MF; Mahmud T; Indra AK; Ganguli-Indra G
    PLoS One; 2015; 10(5):e0125322. PubMed ID: 25938491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck.
    Mandal M; Younes M; Swan EA; Jasser SA; Doan D; Yigitbasi O; McMurphey A; Ludwick J; El-Naggar AK; Bucana C; Mills GB; Myers JN
    Oral Oncol; 2006 Apr; 42(4):430-9. PubMed ID: 16442835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
    Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM
    BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.
    Ji WT; Chen HR; Lin CH; Lee JW; Lee CC
    PLoS One; 2014; 9(2):e88952. PubMed ID: 24586454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
    Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
    Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
    Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.